| Ident. | Authors (with country if any) | Title |
|---|
| 000012 |
Oriol Fornés [Canada] ; Jaime Castro-Mondragon [Norvège] ; Aziz Khan [Norvège] ; Robin Van Der Lee [Canada] ; Xi Zhang [Canada] ; Phillip Richmond [Canada] ; Bhavi Modi [Canada] ; Solenne Correard [Canada] ; Marius Gheorghe [Norvège] ; Damir Baranaši [Royaume-Uni] ; Walter Santana-Garcia [France] ; Ge Tan [Suisse] ; Jeanne Chèneby [France] ; Benoit Ballester [France] ; François Parcy [France] ; Albin Sandelin [Danemark] ; Boris Lenhard [Royaume-Uni] ; Wyeth Wasserman [Canada] ; Anthony Mathelier [Norvège] | JASPAR 2020: update of the open-access database of transcription factor binding profiles. |
| 000113 |
C. Gardiner [Canada] ; J. Veall [Canada] ; S. Lockhart [Canada] | The use of UV fluorescent powder for COVID-19 airway management simulation training. |
| 000115 |
B. Coutard [France] ; C. Valle [France] ; X. De Lamballerie [France] ; B. Canard [France] ; N. G. Seidah [Canada] ; E. Decroly [France] | The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade |
| 000147 |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada] | The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. |
| 000151 |
Peter P. Liu [Canada] ; Alice Blet [France] ; David Smyth [Canada] ; Hongliang Li [République populaire de Chine] | The Science Underlying COVID-19: Implications for the Cardiovascular System. |
| 000173 |
Lyndon Jones [Canada] ; Karen Walsh [Canada] ; Mark Willcox [Australie] ; Philip Morgan [Royaume-Uni] ; Jason Nichols [États-Unis] | The COVID-19 pandemic: Important considerations for contact lens practitioners |
| 000191 |
Waleed Alhazzani [Canada] ; Morten Hylander M Ller [Danemark] ; Yaseen M. Arabi ; Mark Loeb [Canada] ; Michelle Ng Gong [États-Unis] ; Eddy Fan [Canada] ; Simon Oczkowski [Canada] ; Mitchell M. Levy [États-Unis] ; Lennie Derde [Pays-Bas] ; Amy Dzierba [États-Unis] ; Bin Du [République populaire de Chine] ; Michael Aboodi [États-Unis] ; Hannah Wunsch ; Maurizio Cecconi [Italie] ; Younsuck Koh [Corée du Sud] ; Daniel S. Chertow [États-Unis] ; Kathryn Maitland [Royaume-Uni] ; Fayez Alshamsi [Émirats arabes unis] ; Emilie Belley-Cote [Canada] ; Massimiliano Greco [Italie] ; Matthew Laundy [Royaume-Uni] ; Jill S. Morgan [États-Unis] ; Jozef Kesecioglu [Pays-Bas] ; Allison Mcgeer [Canada] ; Leonard Mermel [États-Unis] ; Manoj J. Mammen [États-Unis] ; Paul E. Alexander [Canada] ; Amy Arrington [États-Unis] ; John E. Centofanti [Canada] ; Giuseppe Citerio [Italie] ; Bandar Baw [Canada, Arabie saoudite] ; Ziad A. Memish ; Naomi Hammond [Australie] ; Frederick G. Hayden [États-Unis] ; Laura Evans [États-Unis] ; Andrew Rhodes [Royaume-Uni] | Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) |
| 000226 |
Rossella Porcheddu ; Caterina Serra [Italie] ; David Kelvin [République populaire de Chine] ; Nikki Kelvin [Canada] ; Salvatore Rubino [Italie] | Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. |
| 000314 |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Emma Woolner [Canada] ; Jason K. Perry [États-Unis] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Gotte [Canada] | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. |
| 000355 |
Houman Khosravani [Canada] ; Phavalan Rajendram [Canada] ; Lowyl Notario [Canada] ; Martin G. Chapman [Canada] ; Bijoy K. Menon [Canada] | Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic. |
| 000371 |
Sai Krishna Gudi [Canada] ; Komal Krishna Tiwari [Canada] | Preparedness and Lessons Learned from the Novel Coronavirus Disease. |
| 000392 |
Isaac I. Bogoch [Canada] ; Alexander Watts [Canada] ; Andrea Thomas-Bachli [Canada] ; Carmen Huber [Canada] ; Moritz U G. Kraemer [Royaume-Uni] ; Kamran Khan [Canada] | Potential for global spread of a novel coronavirus from China. |
| 000410 |
Isaac I. Bogoch [Canada] ; Alexander Watts [Canada] ; Andrea Thomas-Bachli [Canada] ; Carmen Huber [Canada] ; Moritz U G. Kraemer [Royaume-Uni] ; Kamran Khan [Canada] | Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. |
| 000444 |
Arinjay Banerjee [Canada] ; Michelle L. Baker [Australie] ; Kirsten Kulcsar [États-Unis] ; Vikram Misra [Canada] ; Raina Plowright [États-Unis] ; Karen Mossman [Canada] | Novel Insights Into Immune Systems of Bats |
| 000486 |
Jessica J. Bartoszko [Canada] ; Mohammed Abdul Malik Farooqi [Canada] ; Waleed Alhazzani [Canada] ; Mark Loeb [Canada] | Medical Masks vs N95 Respirators for Preventing COVID-19 in Health Care Workers A Systematic Review and Meta-Analysis of Randomized Trials. |
| 000563 |
Chad R. Wells ; Pratha Sah ; Seyed M. Moghadas [Canada] ; Abhishek Pandey ; Affan Shoukat ; Yaning Wang [République populaire de Chine] ; Zheng Wang ; Lauren A. Meyers ; Burton H. Singer ; Alison P. Galvani | Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak |
| 000640 |
Jan Deprest ; Marc Van Ranst [Belgique] ; Lore Lannoo ; Emma Bredaki [Royaume-Uni] ; Greg Ryan [Canada] ; Anna David [Royaume-Uni] ; Jute Richter ; Tim Van Mieghem [Canada] | Feto-placental surgeries during the covid-19 pandemic: starting the discussion. |
| 000647 |
Xuhua Xia [Canada] | Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense. |
| 000690 |
Ruichen Wang [République populaire de Chine] ; Xu Zhang [République populaire de Chine] ; David M. Irwin [Canada] ; Yongyi Shen [République populaire de Chine] | Emergence of SARS-like coronavirus poses new challenge in China |
| 000719 |
Jason N. Katz [États-Unis] ; Shashank S. Sinha [États-Unis] ; Carlos L. Alviar [États-Unis] ; David M. Dudzinski [États-Unis] ; Ann Gage [États-Unis] ; Samuel B. Brusca [États-Unis] ; M Casey Flanagan [États-Unis] ; Timothy Welch [États-Unis] ; Bram J. Geller [États-Unis] ; P Elliott Miller [États-Unis] ; Sergio Leonardi [Italie] ; Erin A. Bohula [États-Unis] ; Susanna Price [Royaume-Uni] ; Sunit-Preet Chaudhry [États-Unis] ; Thomas S. Metkus [États-Unis] ; Connor G. O'Brien [États-Unis] ; Alessandro Sionis [Espagne] ; Christopher F. Barnett [États-Unis] ; Jacob C. Jentzer [États-Unis] ; Michael A. Solomon [États-Unis] ; David A. Morrow [États-Unis] ; Sean Van Diepen [Canada] | Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic: An International Perspective. |
| 000730 |
Buddhisha Udugama [Canada] ; Pranav Kadhiresan [Canada] ; Hannah N. Kozlowski [Canada] ; Ayden Malekjahani [Canada] ; Matthew Osborne [Canada] ; Vanessa Y. C. Li [Canada] ; Hongmin Chen [Canada] ; Samira Mubareka [Canada] ; Jonathan B. Gubbay [Canada] ; Warren C. W. Chan [Canada] | Diagnosing COVID-19: The Disease and Tools for Detection |
| 000766 |
Daniel J. Drucker [Canada] | Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications. |
| 000940 |
Ludmila Prokunina-Olsson [États-Unis] ; Noémie Alphonse [Royaume-Uni] ; Ruth E. Dickenson [Royaume-Uni] ; Joan E. Durbin [États-Unis] ; Jeffrey S. Glenn [États-Unis] ; Rune Hartmann [Danemark] ; Sergei V. Kotenko [États-Unis] ; Helen M. Lazear [États-Unis] ; Thomas R. O'Brien [États-Unis] ; Charlotte Odendall [Royaume-Uni] ; Olusegun O. Onabajo [États-Unis] ; Helen Piontkivska [États-Unis] ; Deanna M. Santer [Canada] ; Nancy C. Reich [États-Unis] ; Andreas Wack [Royaume-Uni] ; Ivan Zanoni [États-Unis] | COVID-19 and emerging viral infections: The case for interferon lambda. |
| 000965 |
Justine R. Horne [Canada] ; Marie-Claude Vohl [Canada] | Biological plausibility for interactions between dietary fat, resveratrol, ACE2 and SARS-CoV illness severity. |
| 000978 |
Salvatore Rubino [Italie] ; Nikki Kelvin [Canada] ; Jesús F. Bermejo-Martin [Espagne] ; David Kelvin [Canada] | As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation. |
| 000993 |
Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine] | Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target |
| 000A60 |
Robyn Ralph [Canada] ; Jocelyne Lew [Canada] ; Tiansheng Zeng [République populaire de Chine] ; Magie Francis [Canada] ; Bei Xue [République populaire de Chine] ; Melissa Roux [Canada] ; Ali Toloue Ostadgavahi [Canada] ; Salvatore Rubino [Italie] ; Nicholas J. Dawe [Canada] ; Mohammed N. Al-Ahdal [Arabie saoudite] ; David J. Kelvin [République populaire de Chine] ; Christopher D. Richardson [Canada] ; Jason Kindrachuk [Canada] ; Darryl Falzarano [Canada] ; Alyson Anne Kelvin [Canada] | 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. |
| 000A88 |
Ronald Keith [Australie] ; Zhiqiu Lin [Canada] | SARS in Chinese Politics and Law |
| 000A98 |
Paul K. S. Chan [République populaire de Chine, Hong Kong] ; W. K. To [République populaire de Chine] ; Esther Y. M. Liu [République populaire de Chine] ; T. K. Ng [République populaire de Chine] ; John S. Tam [République populaire de Chine] ; Joseph J. Y. Sung [République populaire de Chine] ; Jean-Michel Lacroix [Canada] ; Michel Houde [Canada] | Evaluation of a peptide‐based enzyme immunoassay for anti‐SARS coronavirus IgG antibody |
| 000B08 |
Idris Nasir Abdullahi [Nigeria] ; Anthony Uchenna Emeribe [Nigeria] ; Jelili Olaide Mustapha [Canada] ; Samuel Ayobami Fasogbon [Nigeria] ; Igr Bassey Ofor [Nigeria] ; Imodoye Sikiru Opeyemi [Nigeria] ; Chibueze Obi-George [Nigeria] ; Animasaun Olawale Sunday [Nigeria] ; Justin Nwofe [Royaume-Uni] | Exploring the genetics, ecology of SARS-COV-2 and climatic factors as possible control strategies against COVID-19 |
